| 1 |
Kitahara CM, Sosa JA. The changing incidence of thyroid cancer [J]. Nat Rev Endocrinol, 2016, 12(11): 646-653.
|
| 2 |
DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014 [J]. CA Cancer J Clin, 2014, 64(4): 252-271.
|
| 3 |
Choi Y, Jung S. Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis [J]. Thyroid, 2020, 30(5): 720-731.
|
| 4 |
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018 [J]. CA Cancer J Clin, 2018, 68(1): 7-30.
|
| 5 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J]. Thyroid, 2016, 26(1): 1-133.
|
| 6 |
Pace-Asciak P, Russell JO, Tufano RP. The treatment of thyroid cancer with radiofrequency ablation [J]. Tech Vasc Interv Radiol, 2022, 25(2): 100825.
|
| 7 |
Zhu Y, Che Y, Gao S, et al. Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study [J]. Int J Hyperthermia, 2021, 38(1): 1225-1232.
|
| 8 |
Cho SJ, Baek JH, Chung SR, et al. Thermal ablation for small papillary thyroid cancer: a systematic review [J]. Thyroid, 2019, 29(12): 1774-1783.
|
| 9 |
Dupuy DE, Monchik JM, Decrea C, et al. Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy [J]. Surgery, 2001, 130(6): 971-977.
|
| 10 |
Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma [J]. Ann Surg, 2006, 244(2): 296-304.
|
| 11 |
Kim JH, Baek JH, Sung JY, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery [J]. Int J Hyperthermia, 2017, 33(2): 212-219.
|
| 12 |
Sinclair CF, Baek JH, Hands KE, et al. General principles for the safe performance, training, and adoption of ablation techniques for benign thyroid nodules: an American Thyroid Association Statement [J]. Thyroid®, 2023, 33(10): 1150-1170.
|
| 13 |
中华医学会内分泌学分会, 中华医学会外科学分会内分泌学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南 [J]. 中华内分泌代谢杂志, 2012, 28(10): 779-797.
|
| 14 |
Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations [J]. Korean J Radiol, 2012, 13(2): 117-125.
|
| 15 |
葛明华, 徐栋. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗浙江省专家共识(2015版) [J]. 中国普通外科杂志, 2016, 25(7): 944-946.
|
| 16 |
Gao M, Ge M, Ji Q, et al. 2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma [J]. Cancer Biol Med, 2017, 14(3): 203-211.
|
| 17 |
Kim J, Baek JH, Lim HK, et al. 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology [J]. Korean J Radiol, 2018, 19(4): 632-655.
|
| 18 |
葛明华, 徐栋, 杨安奎, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版) [J]. 中国肿瘤, 2018, 27(10): 768-773.
|
| 19 |
中国医师协会超声医师分会. 甲状腺微小乳头状癌热消融诊疗指征专家共识 [J/CD]. 中华医学超声杂志(电子版), 2019, 16(8): 571-574.
|
| 20 |
中国临床肿瘤学会指南工作委员会甲状腺癌专家委员会. 中国临床肿瘤学会(CSCO)持续/复发及转移性分化型甲状腺癌诊疗指南-2019 [J]. 肿瘤预防与治疗, 2019, 32(12): 1051-1079.
|
| 21 |
Mauri G, Hegedüs L, Bandula S, et al. European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions [J]. Eur Thyroid J, 2021, 10(3): 185-197.
|
| 22 |
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021 [J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1200.
|
| 23 |
葛明华, 高明, 程若川. 中国肿瘤整合诊治指南(CACA)——甲状腺癌 [M]. 天津: 天津科学技术出版社, 2022: 1-138.
|
| 24 |
中华医学会内分泌学分会, 中华医学会外科学分会甲状腺及代谢外科学组, 中国抗癌协会头颈肿瘤专业委员会, 等. 甲状腺结节和分化型甲状腺癌诊治指南(第二版) [J]. 中华内分泌代谢杂志, 2023, 39(3): 181-226.
|
| 25 |
中国抗癌协会肿瘤消融治疗专业委员会, 肿瘤消融专家委员会中国临床肿瘤学会, 中国医师协会介入医师分会肿瘤消融专业委员会, 等. 甲状腺乳头状癌热消融治疗专家共识(2024版)[J]. 中华内科杂志, 2024, 63(4): 355-364.
|
| 26 |
Ha EJ, Lee MK, Baek JH, et al. Radiofrequency Ablation for Recurrent Thyroid Cancers: 2025 Korean Society of Thyroid Radiology Guideline [J]. Korean J Radiol, 2025, 26(1): 10-28.
|
| 27 |
Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2009, 19(11): 1167-1214.
|
| 28 |
嵇庆海, 程若川, 田文, 等. 对《甲状腺乳头状癌热消融治疗专家共识(2024版)》部分内容的探讨 [J]. 中华耳鼻咽喉头颈外科杂志, 2024, 59(10): 1088-1093.
|
| 29 |
Yan L, Li X, Li Y, et al. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma [J]. Eur Radiol, 2023, 33(1): 730-740.
|
| 30 |
Han ZY, Dou JP, Zheng L, et al. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study [J]. Eur Radiol, 2023, 33(11): 7942-7951.
|
| 31 |
Guo MH, Dou JP, Zheng L, et al. Ultrasound-guided microwave ablation versus surgery for solitary T1bN0M0 papillary thyroid carcinoma: a prospective multicenter study [J]. Eur Radiol, 2024, 34(1): 569-578.
|
| 32 |
Nguyen VC, Park JS, Song CM, et al. Efficacy and oncologic outcomes of thermal ablation techniques in the treatment of primary low-risk papillary thyroid carcinoma: a systematic review and network meta-analysis [J]. Head Neck, 2025, 47(2): 759-775.
|
| 33 |
Jeong SY, Baek SM, Shin S, et al. Radiofrequency ablation of low-risk papillary thyroid microcarcinoma: a retrospective cohort study including patients with more than 10 years of follow-up [J]. Thyroid, 2025, 35(2): 143-152.
|
| 34 |
Song Q, Gao H, Ren L, et al. Radiofrequency ablation versus total thyroidectomy in patients with papillary thyroid microcarcinoma located in the isthmus: a retrospective cohort study [J]. Int J Hyperthermia, 2021, 38(1): 708-714.
|
| 35 |
陈治光, 何文, 张巍. 甲状腺微小乳头状癌的热消融治疗现状与展望 [J]. 中国医学影像学杂志, 2022, 30(8): 856-860.
|
| 36 |
Yan L, Zhang M, Song Q, et al. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study [J]. Eur Radiol, 2022, 32(2): 1216-1226.
|
| 37 |
Wu J, Zhao Z, Cao X, et al. A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule [J]. Int J Hyperthermia, 2021, 38(1): 1217-1224.
|
| 38 |
Zheng L, Dou JP, Han ZY, et al. Microwave ablation for papillary thyroid microcarcinoma with and without US-detected capsule invasion: a multicenter prospective cohort study [J]. Radiology, 2023, 307(3): e220661.
|
| 39 |
Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why? [J]. Thyroid, 2017, 27(6): 751-756.
|
| 40 |
Wang LY, Nixon IJ, Palmer FL, et al. Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: is there a need for change in the AJCC classification system? [J]. Surgery, 2014, 156(6): 1484-1489, discussion 1489-1490.
|
| 41 |
Xiao J, Zhang Y, Zhang M, et al. Ultrasonography-guided radiofrequency ablation vs. Surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: a comparative study [J]. Clin Endocrinol (Oxf), 2021, 94(4): 684-691.
|
| 42 |
He H, Wu R, Zhao J, et al. Ultrasound-guided radiofrequency ablation versus surgical resection for the treatment of T1bN0M0 papillary thyroid carcinoma in different age groups [J]. Front Endocrinol (Lausanne), 2021, 12: 734432.
|